about
Corepressors TLE1 and TLE3 interact with HESX1 and PROP1Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?MECHANISMS IN ENDOCRINOLOGY: An update in the genetic aetiologies of combined pituitary hormone deficiencyMANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytomaUpdates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesThe risks of overlooking the diagnosis of secreting pituitary adenomasCombined pituitary hormone deficiency: current and future status.Auto-immune thyroid dysfunction induced by tyrosine kinase inhibitors in a patient with recurrent chordomaWhich patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms.Adrenal myelolipoma: an unusual cause of bilateral highly 18F-FDG-avid adrenal masses.Identifying the Deleterious Effect of Rare LHX4 Allelic Variants, a Challenging IssuePituitary stem cell update and potential implications for treating hypopituitarismPITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism.ISL1 Is Necessary for Maximal Thyrotrope Response to Hypothyroidism.Radiotherapy and radiosurgery in acromegaly.Does first-line surgery still have its place in the treatment of acromegaly?Lanreotide for the treatment of acromegaly.Role of stereotactic radiosurgery in the management of pituitary adenomas.Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment.The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.Contemporary review of large adrenal tumors in a tertiary referral center.18F-FDOPA PET/CT imaging of insulinoma revisited.Non-functioning pituitary adenoma: when and how to operate? What pathologic criteria for typing?A comprehensive review on MEN 2B.Gamma Knife radiosurgery for hypothalamic hamartoma preserves endocrine functions.Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation.Long-term outcome of macroprolactinomas.Disease of adrenal glands.Bilateral neck exploration in patients with primary hyperparathyroidism and discordant imaging results: a single-centre study.Complications Related to the Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Macroadenomas in 300 Consecutive Patients.Preoperative imaging for focused parathyroidectomy: making a good strategy even better.An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.A registry-based study of thyroid paraganglioma: histological and genetic characteristics.Patients lost to follow-up in acromegaly: results of the ACROSPECT study.Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.Radiosurgery: a useful first-line treatment of prolactinomas?
P50
Q24599195-3A2478FB-3C86-45C3-9349-3DCEA7942EFBQ26770396-60953E5D-6445-4CFE-8B7A-6E5FEEF4FCF0Q26770812-182F85B3-36E0-469C-818C-B351D576F70CQ26795670-099EF4E5-DD02-41B1-A998-A5736BF8EBE7Q28076013-F2EDC20A-9A99-472E-B497-9D1987EB7B20Q28076665-FBC65EBC-C9DE-4349-BDDC-AD6B9291068BQ30848681-CCA59C82-4451-4A03-B6FD-2A184A4D3BB5Q33276185-F67DDF94-22CA-4FAA-86D2-7D908C748935Q33493800-6507C80D-E82F-4465-839E-7EDBCF12A754Q34017922-A2F566C9-44F8-4139-99C5-0AA5CA488373Q34160940-3274ED4B-4F8E-4109-A9DF-575536D6ABEFQ34279288-B61A8ADB-5E46-4A63-9CF0-53F0562A4721Q35587203-87BEBAF1-540F-407B-838B-5B20B716EACAQ36014901-C7380ED3-484C-4C4E-A77F-38EEDF9C4C0FQ36067458-900F9B8E-7F86-42D8-88FB-0E9FC79C1F92Q36107279-DAF26748-0754-48AC-821B-E587659EDEDDQ37050494-E589EE6D-FD44-4E8B-A57A-45633A2FC92BQ37432869-85CAEF76-958C-497E-AAB5-2239E8FCBA45Q37521920-887E7030-CC84-4395-ABAC-D265FE8EED52Q37696963-46FD8B39-1DCA-4E28-B1A8-659EF97FD733Q37992191-BEAC6E7A-411C-4317-8DCC-48750DEF37A6Q38006332-3A2F05E2-9B2D-46D6-9DA0-89983EEF5DB8Q38207962-3C42B27E-9592-4EE6-B18C-752BDB903BC2Q38264851-3191CBED-0D92-40C7-BAC8-AEE5A68B40CFQ38526505-F627365A-FE90-4EF2-91C2-264C5083B8CCQ38658971-848B7DAB-6C05-46BC-A177-2EF0EFFF5A82Q38738069-0560065A-80F2-4A2D-AECC-15A736BD9CD7Q38825813-DE179FEA-C497-49F7-B528-5D7F5754C819Q38890175-664AA9BB-A839-4A0D-B5C3-AACF0DE2D2DEQ39192028-5C6E0D90-2D8E-4797-9F0E-F046E9E0EA9BQ39376999-A2594969-0008-4748-9AC5-68C72D0A2ED8Q39453176-B95688DE-6F71-4963-A961-D2EC23EC1C6AQ40173465-54732D64-E9EB-484C-90BE-BD3988A1F490Q40894937-C063CEF5-92F0-4456-BBBE-76EAED14F229Q41503715-CA2FDB5C-BE2D-4B3D-BA79-CCDEF3D60CA8Q41532296-E3191459-7BC6-4FD7-ABD8-D10C75ADD3E7Q41572822-02AECED2-5715-44DF-AD93-02ADB5B9723FQ42646372-3FA0E599-ED73-4B78-BE3E-586EB952D0FCQ42655520-EE35F790-CBDD-43FE-9698-834C49983834Q42752188-518304A9-B171-48A5-B846-F069EF9B9013
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Frederic Castinetti
@ast
Frederic Castinetti
@en
Frederic Castinetti
@es
Frederic Castinetti
@nl
Frederic Castinetti
@sl
type
label
Frederic Castinetti
@ast
Frederic Castinetti
@en
Frederic Castinetti
@es
Frederic Castinetti
@nl
Frederic Castinetti
@sl
prefLabel
Frederic Castinetti
@ast
Frederic Castinetti
@en
Frederic Castinetti
@es
Frederic Castinetti
@nl
Frederic Castinetti
@sl
P106
P21
P31
P496
0000-0002-1808-8800